| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.05e-05 | 14 | 10 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.31e-04 | 46 | 10 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.80e-03 | 129 | 10 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.46e-03 | 151 | 10 | 2 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.49e-03 | 152 | 10 | 2 | GO:0022843 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.54e-03 | 182 | 10 | 2 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.62e-03 | 184 | 10 | 2 | GO:0022832 | |
| GeneOntologyMolecularFunction | calmodulin binding | 5.59e-03 | 230 | 10 | 2 | GO:0005516 | |
| GeneOntologyBiologicalProcess | calcium ion import | 1.22e-05 | 98 | 10 | 3 | GO:0070509 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 2.36e-04 | 48 | 10 | 2 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 2.36e-04 | 48 | 10 | 2 | GO:1902656 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle contraction | 3.57e-04 | 59 | 10 | 2 | GO:0045933 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 6.39e-04 | 79 | 10 | 2 | GO:0000380 | |
| GeneOntologyBiologicalProcess | positive regulation of cell division | 1.10e-03 | 104 | 10 | 2 | GO:0051781 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.58e-03 | 509 | 10 | 3 | GO:0006816 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 2.04e-03 | 142 | 10 | 2 | GO:0098659 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 2.04e-03 | 142 | 10 | 2 | GO:0099587 | |
| GeneOntologyBiologicalProcess | regulation of organ growth | 2.07e-03 | 143 | 10 | 2 | GO:0046620 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 2.16e-03 | 146 | 10 | 2 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 2.19e-03 | 147 | 10 | 2 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 2.25e-03 | 149 | 10 | 2 | GO:0051282 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 2.37e-03 | 153 | 10 | 2 | GO:0051208 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 2.40e-03 | 154 | 10 | 2 | GO:0051928 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 1.36e-05 | 12 | 10 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.11e-04 | 46 | 10 | 2 | GO:0005891 | |
| GeneOntologyCellularComponent | calcium channel complex | 5.32e-04 | 73 | 10 | 2 | GO:0034704 | |
| GeneOntologyCellularComponent | T-tubule | 6.22e-04 | 79 | 10 | 2 | GO:0030315 | |
| GeneOntologyCellularComponent | I band | 2.71e-03 | 166 | 10 | 2 | GO:0031674 | |
| GeneOntologyCellularComponent | sarcolemma | 3.52e-03 | 190 | 10 | 2 | GO:0042383 | |
| GeneOntologyCellularComponent | cation channel complex | 5.34e-03 | 235 | 10 | 2 | GO:0034703 | |
| GeneOntologyCellularComponent | sarcomere | 5.97e-03 | 249 | 10 | 2 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 7.14e-03 | 273 | 10 | 2 | GO:0030016 | |
| GeneOntologyCellularComponent | presynaptic membrane | 7.34e-03 | 277 | 10 | 2 | GO:0042734 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 8.02e-03 | 290 | 10 | 2 | GO:0043292 | |
| MousePheno | decreased aerobic running capacity | 1.61e-05 | 15 | 6 | 2 | MP:0003061 | |
| MousePheno | abnormal aerobic fitness | 2.91e-05 | 20 | 6 | 2 | MP:0000348 | |
| MousePheno | abnormal muscle electrophysiology | 7.57e-05 | 32 | 6 | 2 | MP:0004145 | |
| MousePheno | impaired exercise endurance | 3.45e-04 | 68 | 6 | 2 | MP:0012106 | |
| MousePheno | fatigue | 4.54e-04 | 78 | 6 | 2 | MP:0002899 | |
| MousePheno | abnormal exercise endurance | 5.39e-04 | 85 | 6 | 2 | MP:0002332 | |
| MousePheno | abnormal jaw morphology | 9.95e-04 | 530 | 6 | 3 | MP:0000454 | |
| MousePheno | abnormal viscerocranium morphology | 1.38e-03 | 593 | 6 | 3 | MP:0005274 | |
| MousePheno | abnormal axial skeleton morphology | 1.49e-03 | 1458 | 6 | 4 | MP:0002114 | |
| MousePheno | abnormal mandible morphology | 2.29e-03 | 176 | 6 | 2 | MP:0000458 | |
| MousePheno | abnormal cranium morphology | 3.43e-03 | 813 | 6 | 3 | MP:0000438 | |
| MousePheno | abnormal craniofacial bone morphology | 3.60e-03 | 827 | 6 | 3 | MP:0002116 | |
| Domain | VDCC_L_a1su | 1.24e-06 | 4 | 9 | 2 | IPR005446 | |
| Domain | Ca_chan_IQ | 4.33e-06 | 7 | 9 | 2 | PF08763 | |
| Domain | GPHH | 4.33e-06 | 7 | 9 | 2 | PF16905 | |
| Domain | GPHH_dom | 4.33e-06 | 7 | 9 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 4.33e-06 | 7 | 9 | 2 | SM01062 | |
| Domain | VDCC_a1su_IQ | 4.33e-06 | 7 | 9 | 2 | IPR014873 | |
| Domain | VDCCAlpha1 | 9.27e-06 | 10 | 9 | 2 | IPR002077 | |
| Domain | Channel_four-helix_dom | 3.25e-04 | 57 | 9 | 2 | IPR027359 | |
| Domain | - | 3.25e-04 | 57 | 9 | 2 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 1.29e-03 | 114 | 9 | 2 | IPR005821 | |
| Domain | Ion_trans | 1.29e-03 | 114 | 9 | 2 | PF00520 | |
| Domain | EF-hand-dom_pair | 7.89e-03 | 287 | 9 | 2 | IPR011992 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 3.17e-06 | 6 | 7 | 2 | M47762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.16e-05 | 11 | 7 | 2 | M47958 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 1.92e-05 | 14 | 7 | 2 | M47692 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 5.32e-05 | 23 | 7 | 2 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 6.31e-05 | 25 | 7 | 2 | M47948 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.80e-04 | 42 | 7 | 2 | M7169 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.07e-04 | 63 | 7 | 2 | M11187 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.61e-04 | 74 | 7 | 2 | MM15962 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 5.61e-04 | 74 | 7 | 2 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 5.61e-04 | 74 | 7 | 2 | M16376 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 6.39e-04 | 79 | 7 | 2 | M17673 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 7.06e-04 | 83 | 7 | 2 | M8728 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 8.29e-04 | 90 | 7 | 2 | M835 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.04e-03 | 101 | 7 | 2 | M1979 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.35e-03 | 115 | 7 | 2 | M9387 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.19e-03 | 147 | 7 | 2 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.31e-03 | 151 | 7 | 2 | M39329 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 2.78e-03 | 166 | 7 | 2 | M16024 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.19e-03 | 178 | 7 | 2 | M2890 | |
| Pathway | WP_MAPK_SIGNALING | 6.01e-03 | 246 | 7 | 2 | M39597 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 6.74e-03 | 261 | 7 | 2 | M42565 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 7.05e-03 | 267 | 7 | 2 | M10792 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 1.04e-02 | 326 | 7 | 2 | M39379 | |
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 25277766 | ||
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 7635187 | ||
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 1281468 | ||
| Pubmed | Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels. | 2.23e-07 | 3 | 10 | 2 | 9668070 | |
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 17767505 | ||
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 17289261 | ||
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 11206130 | ||
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 2173707 | ||
| Pubmed | mRNA for cardiac calcium channel is expressed during development of skeletal muscle. | 2.23e-07 | 3 | 10 | 2 | 8381753 | |
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 20937870 | ||
| Pubmed | 7.44e-07 | 5 | 10 | 2 | 1335956 | ||
| Pubmed | 1.56e-06 | 7 | 10 | 2 | 9004034 | ||
| Pubmed | 1.56e-06 | 7 | 10 | 2 | 12900400 | ||
| Pubmed | 2.68e-06 | 9 | 10 | 2 | 16382099 | ||
| Pubmed | 7.80e-06 | 15 | 10 | 2 | 24453333 | ||
| Pubmed | 7.80e-06 | 15 | 10 | 2 | 20188150 | ||
| Pubmed | 8.91e-06 | 16 | 10 | 2 | 32994313 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.29e-05 | 560 | 10 | 4 | 21653829 | |
| Pubmed | Defining the molecular character of the developing and adult kidney podocyte. | 5.48e-05 | 39 | 10 | 2 | 21931791 | |
| Pubmed | Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. | 5.77e-05 | 40 | 10 | 2 | 23825951 | |
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 1.63e-04 | 67 | 10 | 2 | 16987237 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.54e-05 | 26 | 8 | 2 | 253 | |
| Coexpression | GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN | 4.61e-05 | 194 | 10 | 3 | M5767 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 56 | 10 | 2 | 55337ff90621e1fea4d747ae2559c0fa61b38dce | |
| ToppCell | Healthy-CD4+_T_activated|World / disease group, cell group and cell class | 4.26e-04 | 140 | 10 | 2 | 407691970ec72a3afb45e431cf48814546b8acff | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.14e-04 | 154 | 10 | 2 | d22902d2922784583f7016453768ed05b14b965e | |
| ToppCell | facs-GAT-Fat-24m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 157 | 10 | 2 | c4a0b6c95d353691fd2846002ce4bc7c2b0edd1c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.69e-04 | 162 | 10 | 2 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.12e-04 | 168 | 10 | 2 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.12e-04 | 168 | 10 | 2 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.12e-04 | 168 | 10 | 2 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-04 | 176 | 10 | 2 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-04 | 178 | 10 | 2 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-04 | 182 | 10 | 2 | cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08 | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.17e-04 | 182 | 10 | 2 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.17e-04 | 182 | 10 | 2 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-04 | 184 | 10 | 2 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-04 | 185 | 10 | 2 | 8314dc608bc837df3037e89afd9db39737374ebc | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 186 | 10 | 2 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-04 | 189 | 10 | 2 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-04 | 189 | 10 | 2 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-04 | 189 | 10 | 2 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-04 | 190 | 10 | 2 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-04 | 190 | 10 | 2 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-04 | 190 | 10 | 2 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-04 | 190 | 10 | 2 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 191 | 10 | 2 | e518c598719119e60c76016c586b1520c258bbcb | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 191 | 10 | 2 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 191 | 10 | 2 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 191 | 10 | 2 | f0c649bb32732c9dd38a0af8ce94d2a4d16de39a | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.97e-04 | 192 | 10 | 2 | 9a2560921b8c0997e1788053004f099439e8f071 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-04 | 192 | 10 | 2 | 0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 7.97e-04 | 192 | 10 | 2 | 7a81652406332afd03a9b3b529e9b5e6c0b54c28 | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|World / disease group, cell group and cell class | 8.05e-04 | 193 | 10 | 2 | c2a2a2c14a7085690262db5c2a70e38db67dee18 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.05e-04 | 193 | 10 | 2 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-04 | 194 | 10 | 2 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.22e-04 | 195 | 10 | 2 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 8.22e-04 | 195 | 10 | 2 | c60982804a74dbe6607c021799ca74af2204aba8 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.30e-04 | 196 | 10 | 2 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-04 | 196 | 10 | 2 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 8.30e-04 | 196 | 10 | 2 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.39e-04 | 197 | 10 | 2 | 4edf043e8f586fd375f56485841fe992a18bf853 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.39e-04 | 197 | 10 | 2 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.39e-04 | 197 | 10 | 2 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 8.47e-04 | 198 | 10 | 2 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.56e-04 | 199 | 10 | 2 | b768496381362f9a2706e0892b5a7a0db82e09ce | |
| Drug | Nilvadipine | 1.74e-06 | 5 | 10 | 2 | DB06712 | |
| Drug | Nisoldipine | 1.74e-06 | 5 | 10 | 2 | DB00401 | |
| Drug | CPU-23 | 2.60e-06 | 6 | 10 | 2 | CID003036051 | |
| Drug | Magnesium Sulfate | 2.60e-06 | 6 | 10 | 2 | DB00653 | |
| Drug | Amlodipine | 3.64e-06 | 7 | 10 | 2 | DB00381 | |
| Drug | Isradipine | 3.64e-06 | 7 | 10 | 2 | DB00270 | |
| Drug | Nitrendipine | 4.85e-06 | 8 | 10 | 2 | DB01054 | |
| Drug | Nifedipine | 4.85e-06 | 8 | 10 | 2 | DB01115 | |
| Drug | Cinnarizine | 6.24e-06 | 9 | 10 | 2 | DB00568 | |
| Drug | Nimodipine | 6.24e-06 | 9 | 10 | 2 | DB00393 | |
| Drug | Felodipine | 9.53e-06 | 11 | 10 | 2 | DB01023 | |
| Drug | Mibefradil | 9.53e-06 | 11 | 10 | 2 | DB01388 | |
| Drug | AC1L1JG6 | 1.58e-05 | 14 | 10 | 2 | CID000005026 | |
| Drug | FPL 64176 | 1.82e-05 | 15 | 10 | 2 | CID000003423 | |
| Drug | Verapamil | 2.08e-05 | 16 | 10 | 2 | DB00661 | |
| Drug | MgSO4.7H2O | 5.18e-05 | 25 | 10 | 2 | CID000024843 | |
| Drug | NSC759576 | 6.68e-05 | 191 | 10 | 3 | CID000003075 | |
| Drug | baclofen | 6.68e-05 | 191 | 10 | 3 | CID000002284 | |
| Drug | IHC-64 | 9.10e-05 | 33 | 10 | 2 | CID000162753 | |
| Drug | CNS 1145 | 9.10e-05 | 33 | 10 | 2 | CID000190902 | |
| Drug | h PM | 1.70e-04 | 45 | 10 | 2 | CID005494424 | |
| Drug | KW-3049 | 2.10e-04 | 50 | 10 | 2 | CID000002324 | |
| Drug | Cinildipine | 2.64e-04 | 56 | 10 | 2 | CID000002752 | |
| Drug | nilvadipine | 3.03e-04 | 60 | 10 | 2 | CID000004494 | |
| Drug | IAA-94 | 3.13e-04 | 61 | 10 | 2 | CID000003667 | |
| Drug | lercanidipine | 3.34e-04 | 63 | 10 | 2 | CID000065866 | |
| Drug | NSC759256 | 3.34e-04 | 63 | 10 | 2 | CID000125889 | |
| Drug | mibefradil | 3.45e-04 | 64 | 10 | 2 | CID000060662 | |
| Drug | gallopamil | 3.78e-04 | 67 | 10 | 2 | CID000001234 | |
| Drug | AC1L2AC7 | 4.01e-04 | 69 | 10 | 2 | CID000068733 | |
| Drug | AC1L1JVU | 4.37e-04 | 72 | 10 | 2 | CID000005229 | |
| Drug | CAS 298-57-7 | 4.49e-04 | 73 | 10 | 2 | CID000002761 | |
| Drug | DBTC | 4.49e-04 | 73 | 10 | 2 | CID000101938 | |
| Drug | ethosuximide | 4.61e-04 | 74 | 10 | 2 | CID000003291 | |
| Drug | nisoldipine | 5.12e-04 | 78 | 10 | 2 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 5.25e-04 | 79 | 10 | 2 | CID005287890 | |
| Drug | AC1NUZ8M | 7.12e-04 | 92 | 10 | 2 | CID000073211 | |
| Drug | manidipine | 7.59e-04 | 95 | 10 | 2 | CID000004008 | |
| Drug | isotetrandrine | 7.91e-04 | 97 | 10 | 2 | CID000005422 | |
| Drug | cadmium | 7.93e-04 | 443 | 10 | 3 | CID000002514 | |
| Drug | nitrendipine | 8.07e-04 | 98 | 10 | 2 | CID000004507 | |
| Drug | isradipine | 8.40e-04 | 100 | 10 | 2 | CID000003784 | |
| Drug | loperamide | 9.25e-04 | 105 | 10 | 2 | CID000003954 | |
| Drug | pyraclofos | 9.43e-04 | 106 | 10 | 2 | CID000093460 | |
| Drug | poly(G | 1.09e-03 | 114 | 10 | 2 | CID000439502 | |
| Drug | lamotrigine | 1.13e-03 | 116 | 10 | 2 | CID000003878 | |
| Drug | AC1NBU2S | 1.15e-03 | 117 | 10 | 2 | CID004473765 | |
| Drug | fluo-3 | 1.25e-03 | 122 | 10 | 2 | CID000104978 | |
| Drug | bepridil | 1.33e-03 | 126 | 10 | 2 | CID000002351 | |
| Drug | amlodipine | 1.33e-03 | 126 | 10 | 2 | CID000002162 | |
| Drug | pimozide | 1.35e-03 | 127 | 10 | 2 | CID000016362 | |
| Drug | mercury | 1.42e-03 | 542 | 10 | 3 | CID000023931 | |
| Drug | phloretin | 1.43e-03 | 131 | 10 | 2 | CID000004788 | |
| Drug | Barium permanganate | 1.48e-03 | 133 | 10 | 2 | CID000024587 | |
| Drug | lanthanum | 1.54e-03 | 136 | 10 | 2 | CID000023926 | |
| Drug | isovalerate | 1.71e-03 | 143 | 10 | 2 | CID000010430 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 6.20e-07 | 4 | 10 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 6.47e-05 | 36 | 10 | 2 | DOID:11723 (implicated_via_orthology) | |
| Disease | depressive symptom measurement, stressful life event measurement | 1.26e-04 | 50 | 10 | 2 | EFO_0007006, EFO_0007781 | |
| Disease | Manic Disorder | 2.54e-04 | 71 | 10 | 2 | C0024713 | |
| Disease | Manic | 3.06e-04 | 78 | 10 | 2 | C0338831 | |
| Disease | Depression, Bipolar | 3.14e-04 | 79 | 10 | 2 | C0005587 | |
| Disease | resting heart rate | 1.11e-03 | 149 | 10 | 2 | EFO_0004351 | |
| Disease | urinary albumin to creatinine ratio | 1.59e-03 | 179 | 10 | 2 | EFO_0007778 | |
| Disease | alcohol dependence | 1.67e-03 | 183 | 10 | 2 | MONDO_0007079 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNNNQYNRSSNSNGG | 531 | Q9UNH5 | |
| TNNSDSNGNGNNGND | 521 | Q9NZW4 | |
| NYNINVNDDNNNAGS | 21 | Q9NS71 | |
| YSSTGSNANINNANN | 1806 | Q13936 | |
| TNNANANVAYGNSNH | 1661 | Q13698 | |
| GYSQNRWGNNNRDNN | 666 | Q9BUJ2 | |
| NRDNNNSNNRGSYNR | 676 | Q9BUJ2 | |
| NSNNRGSYNRAPQQQ | 681 | Q9BUJ2 | |
| LSGNQNNNNNYQAAN | 871 | Q9Y6H5 | |
| NGSYLNQAHQSNGNQ | 1056 | Q9C0B9 | |
| GNYSGNNNNNSNNDF | 846 | Q9Y2W1 | |
| NFNNLSNHSGNNVNY | 541 | Q6IQ21 | |
| SNHSGNNVNYNASQQ | 546 | Q6IQ21 |